Egle Therapeutics Strengthens its Leadership Team with the Appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer (si apre in una nuova scheda)
Leggi l'articolo (si apre in una nuova scheda)Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.
Egle Therapeutics Strengthens its Leadership Team with the Appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer (si apre in una nuova scheda)
Leggi l'articolo (si apre in una nuova scheda)Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.
Egle Therapeutics Strengthens its Leadership Team with the Appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer (si apre in una nuova scheda)
Leggi l'articolo (si apre in una nuova scheda)Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.
Egle Therapeutics Strengthens its Leadership Team with the Appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer (si apre in una nuova scheda)
Leggi l'articolo (si apre in una nuova scheda)Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.
Egle Therapeutics Strengthens its Leadership Team with the Appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer (si apre in una nuova scheda)
Leggi l'articolo (si apre in una nuova scheda)Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.
Egle Therapeutics Strengthens its Leadership Team with the Appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer (si apre in una nuova scheda)
Leggi l'articolo (si apre in una nuova scheda)Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.
Egle Therapeutics Strengthens its Leadership Team with the Appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer (si apre in una nuova scheda)
Leggi l'articolo (si apre in una nuova scheda)Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.
Egle Therapeutics Strengthens its Leadership Team with the Appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer (si apre in una nuova scheda)
Leggi l'articolo (si apre in una nuova scheda)Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.
Egle Therapeutics Strengthens its Leadership Team with the Appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer (si apre in una nuova scheda)
Leggi l'articolo (si apre in una nuova scheda)Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.
Egle Therapeutics Strengthens its Leadership Team with the Appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer (si apre in una nuova scheda)
Leggi l'articolo (si apre in una nuova scheda)Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.
Egle Therapeutics Strengthens its Leadership Team with the Appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer (si apre in una nuova scheda)
Leggi l'articolo (si apre in una nuova scheda)Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.
Egle Therapeutics Strengthens its Leadership Team with the Appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer (si apre in una nuova scheda)
Leggi l'articolo (si apre in una nuova scheda)Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.
Egle Therapeutics Strengthens its Leadership Team with the Appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer (si apre in una nuova scheda)
Leggi l'articolo (si apre in una nuova scheda)Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.
Egle Therapeutics Strengthens its Leadership Team with the Appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer (si apre in una nuova scheda)
Leggi l'articolo (si apre in una nuova scheda)Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.
Egle Therapeutics Strengthens its Leadership Team with the Appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer (si apre in una nuova scheda)
Leggi l'articolo (si apre in una nuova scheda)Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.
Egle Therapeutics Strengthens its Leadership Team with the Appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer (si apre in una nuova scheda)
Leggi l'articolo (si apre in una nuova scheda)Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.
Egle Therapeutics Strengthens its Leadership Team with the Appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer (si apre in una nuova scheda)
Leggi l'articolo (si apre in una nuova scheda)Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.
Egle Therapeutics Strengthens its Leadership Team with the Appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer (si apre in una nuova scheda)
Leggi l'articolo (si apre in una nuova scheda)Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.
Egle Therapeutics Strengthens its Leadership Team with the Appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer (si apre in una nuova scheda)
Leggi l'articolo (si apre in una nuova scheda)Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.
Egle Therapeutics Strengthens its Leadership Team with the Appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer (si apre in una nuova scheda)
Leggi l'articolo (si apre in una nuova scheda)Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.
Egle Therapeutics Strengthens its Leadership Team with the Appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer (si apre in una nuova scheda)
Leggi l'articolo (si apre in una nuova scheda)Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.
Egle Therapeutics Strengthens its Leadership Team with the Appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer (si apre in una nuova scheda)
Leggi l'articolo (si apre in una nuova scheda)Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.
Egle Therapeutics Strengthens its Leadership Team with the Appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer (si apre in una nuova scheda)
Leggi l'articolo (si apre in una nuova scheda)Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.
Egle Therapeutics Strengthens its Leadership Team with the Appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer (si apre in una nuova scheda)
Leggi l'articolo (si apre in una nuova scheda)Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.
L'intelligenza artificiale parla anche il reatino: «Non dobbiamo aver paura, può essere una grande opportunità» (si apre in una nuova scheda)
Leggi l'articolo (si apre in una nuova scheda)L'intelligenza artificiale parla anche reatino. [...] dieci anni fa, in tempi ancora non sospetti c'era già chi, come Alessandro Acciai, aveva scelto di dedicare la propria vita allo studio delle architetture che emulano le reti neurali umane. [...] Trentasei anni e un curriculum che, dalla facoltà di Lettere e Filosofia di Roma Tre lo ha spinto verso la laurea magistrale in Scienze cognitive, fino alla Scuola internazionale superiore di studi avanzati di Trieste e alla Scuola di specializzazione del Cnr di Roma.
La speranza di un rene (si apre in una nuova scheda)
Leggi l'articolo (si apre in una nuova scheda)Si chiama Richard Slayman, ha 62 anni, ed è il primo essere umano vivente al mondo ad aver ricevuto un rene di maiale geneticamente modificato. [...] E quali sono gli aspetti bioetici da tener presente quando si effettua uno xenotrapianto e se questa tecnica diventerà una pratica abituale? Rispondono Emanuele Cozzi, [...] e Mariachiara Tallacchini, docente di scienza, diritto e democrazia alla Scuola Internazionale di Studi Superiori Avanzati (SISSA) di Trieste.
MITTEILUNG UEBERMITTELT VON BUSINESS WIRE. FUER DEN INHALT IST ALLEIN DAS BERICHTENDE UNTERNEHMEN VERANTWORTLICH. (si apre in una nuova scheda)
Leggi l'articolo (si apre in una nuova scheda)Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.
MITTEILUNG UEBERMITTELT VON BUSINESS WIRE. FUER DEN INHALT IST ALLEIN DAS BERICHTENDE UNTERNEHMEN VERANTWORTLICH. (si apre in una nuova scheda)
Leggi l'articolo (si apre in una nuova scheda)Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.
SMACT fa incontrare ricerca e impresa (si apre in una nuova scheda)
Leggi l'articolo (si apre in una nuova scheda)SMACT, il Centro di Competenza Industria 4.0, offre consulenza e formazione alle aziende che vogliono aumentare il proprio potenziale innovativo SMACT è uno degli otto Centri di Competenza Industria 4.0 nati per favorire l'incontro tra ricerca e impresa. I soci fondatori di SMACT sono 8 università del Triveneto (Padova, Verona, Ca' Foscari, IUAV, Trento, Bolzano, Udine e SISSA di Trieste).
Arte e scienza al servizio della zona umida Schiavetti
Si sono da poco conclusi tre workshop che hanno visto protagonisti gli allievi e le allieve di alcune classi dell'Isis Brignoli Einaudi Marconi di Staranzano e Gradisca, coadiuvati dai docenti, che hanno lavorato assieme a scienziati, videomaker, artisti, ricercatori e comunicatori scientifici, esplorando una zona affascinante e ancora poco conosciuta: il biotopo Schiavetti. [...] Curatore dei progetti Francesco Scarel, ricercatore, divulgatore e docente di comunicazione scientifica al Master della Sissa.
In edicola.
Facing Harvard inhospitality, academic delegation seeks to expand dialogue on Israel (si apre in una nuova scheda)
Leggi l'articolo (si apre in una nuova scheda)Facing an inhospitable environment with antisemitism and discrimination on campus, Harvard University academics have sought to engage in dialogue and discourse in Israel by joining a delegation of professors from six universities last Sunday. [...] Together they worked with Israel Destination to organize a delegation of 31 academics from Harvard, Stanford, Dartmouth, the Italian International School for Advanced Studies, and the University Kore of Enna.
Facing Harvard inhospitality, academic delegation seeks to expand dialogue on Israel (si apre in una nuova scheda)
Leggi l'articolo (si apre in una nuova scheda)Facing an inhospitable environment with antisemitism and discrimination on campus, Harvard University academics have sought to engage in dialogue and discourse in Israel by joining a delegation of professors from six universities last Sunday. [...] Together they worked with Israel Destination to organize a delegation of 31 academics from Harvard, Stanford, Dartmouth, the Italian International School for Advanced Studies, and the University Kore of Enna.
«Potere e tecnologia nel mondo di oggi» (si apre in una nuova scheda)
Leggi l'articolo (si apre in una nuova scheda)«George Orwell 1984, quarant'anni di distopie», ovvero un viaggio nei «peggiori dei mondi possibili», tra distopie e apocalissi climatiche. Stasera (ore 21.15) alla Mole di Ancona 'Popsophia' ospita Michele Bellone, giornalista scientifico e docente di storytelling e comunicazione della scienza alla SISSA di Trieste e all'Università di Pavia.
«Potere e tecnologia nel mondo di oggi»
«George Orwell 1984, quarant'anni di distopie», ovvero un viaggio nei «peggiori dei mondi possibili», tra distopie e apocalissi climatiche. Stasera (ore 21.15) alla Mole di Ancona 'Popsophia' ospita Michele Bellone, giornalista scientifico e docente di storytelling e comunicazione della scienza alla SISSA di Trieste e all'Università di Pavia.
In edicola.
Alla scuola "Manzini" di San Daniele si parla di neuroscienze (si apre in una nuova scheda)
Leggi l'articolo (si apre in una nuova scheda)Prosegue martedì 26 marzo la prima edizione di "Dopo la campanella - serate culturali al Manzini" [...]. La terza serata sarà all'insegna delle neuroscienze, con la professoressa Federica Marcuzzi [...]. Federica Marcuzzi, dopo la maturità scientifica, si laurea in biotecnologie all'università di Udine. Inizialmente appassionata di genetica, durante la laurea specialistica si innamora della neurobiologia e decide di iscriversi alla Scuola Internazionale Superiore di Studi Avanzati (SISSA) di Trieste.
Collaborazioni con Iran, Cina e Nord Corea E per i «pacifisti» l'unico problema è Israele
Vanno bene gli accordi con l'Iran, e con la Cina, vanno bene anche le collaborazioni con la Corea del Nord, o con chissà quale altro regime dittatoriale. [...] No problem. Il problema, per i pacifisti, è soltanto Israele, come al solito. [...] Risulta che fisici ricercatori dell'università Kim Il-sung di Pyongyang, il principale ateneo della Corea del Nord abbiano in passato stretto un accordo con la Scuola internazionale superiore di studi avanzati (Sissa) di Trieste.
In edicola.
Rassegna stampa
Pagina 149 di 347
Leggi l'articolo